Approach

We enable the swift and convenient administration of medications, targeting the deepest regions of the lungs for localized effectiveness or systemic circulation.

We are cost driven  with the ambition to always make high quality medicines at affordable cost for all linked to high manufacture efficiency.

With a deep technology approach including IA generative, PATs, CFD, equipment learning, we are cutting development time with lower risks.

From scratch to market, we are changing the game by offering new perspectives to patients with chronic respiratory diseases and systemic diseases.